Skip to main content

White House annouces private sector actor to reduce organ transplant waitlist



The White House today made an announcement that will affect thousands of organ transplant recipeints in USA to reduce their waiting time and enable to the number of transplants per day to increase dramatically. 




According to research 100% of USA population favours Organ donation and would be ready to donate their organs but only 50% end up doing so. 

So according to the three pronged approach initiated by Mr. Barack Obama includes developments in the following three areas has been considered: 

1. Development of New Technologies 

One the first announcements was to support newer technologies that would allow for organ replacment in the future with new tissue development and other technologies like 3D printing. 



"New breakthroughs in bioengineering, transplantation, and organ preservation can further increase the number of organ transplants and improve outcomes," the President's office said.


2. Reducing time taken for Donor Organ to reach from Donor to Recipient

Another initiative announced aimed to reduce the wastage of organs from one to to the end due to negligence on logistics. More than 30 transplant centers have said they'll share data and best practices for kidney transplants for hard-to-match patients. This could help almost 1,000 more people a year obtain transplants, the White House said. The vast majority of transplant patients need kidneys.

3. Social Media and annoucement of Organ Donor Status 

The last inniviative is to announce Organ donation from Millitary families into Non-Millitary familes, Across blood type donations, Donations from HIV +ve to Non Hiv -ve and vice versa....basically allow organ donations to happen universally across the board irrespective of the blood type and health of the donor. 

This innitiative has been announced along with the NGO ORGANIZE based in New York that will make it easier for Donors and Organs to connect to each other. 

Here is the quick video on the idea they plan to execute. 



Along with the moonshot to cancer this iniviative has been highly well recieved by the citizens of US and the world. We applaud the President of taking steps in healthcare that no one has taken before.


For a full a total report, coverage and video footage you click on the link below

Source - The White House 


Comments

Popular posts from this blog

5 questions about Artificial Implantable Kidney to understand it better

Source - http://timesofindia.indiatimes.com/india/artificial-kidney-may-hit-market-by-end-of-decade/articleshow/56801777.cms What is it? An implantable kidney that works due to silicon microchips. These microchips will house living kidney cells that will grow on an around the microchips. These cells will then mimic the natural action of the kidney. How does it work?  It will work in the same way that a regular kidney works with the patients blood flow. The living kidney cells will create membrane that will filter your blood the way a normal kidney does. Also because it is out of reach from the bodys immune system response it cannot be rejected as with an organ transplant. Who is making it? It is being developed by University of California San Francisco (Shuvo Ray) and Vanderbilt University Medical Centre, Nephrology (William H Fissel). Fissell has been working on the implantable artificial kidney for more than a decade with University of California San Franc...

Prices of Immunosuppressants drop in India

There is finally some good news for transplant patients in India. The National Pharmacuetical pricing authority of India has reduced some of the cost of major immunosuppresants by almost 20-50%.  The most important among these is Prograf and Pangraf one of the main immunosuppresant for Kidney Transplant Patients. The cost of dailysis, transplant and the follow up medicine is too prohibitve for many Indian patients. further low education and awareness levels contributed to patients skipping medicine to save money or taking them only every altrernate day. A lot others preffered to stay on dailysis due to not being able to afford the cost of transplant and better medicines. While the cost of Tacrolimus has been dractically reduced the other drugs by Roche and Novartis haven't seen as much reduction. We hope the government will be able to bring down the price of all the drugs and blood tests realted to transplant and give a huge boost to organ donation in India.  Fruth...